Company: TXG
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001770787-25-000032
Chunk: 7

Company: 10x Genomics, Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
371,329 $18 $— $371,347 

9

Table of Contents10x Genomics, Inc.Notes to Unaudited Condensed Consolidated Financial Statements

The contractual maturities of marketable securities as of March 31, 2025 were all less than one year.The Company incurred no material gross realized gains or losses from available-for-sales debt securities during the three months ended March 31, 2025 or March 31, 2024. The available-for-sale debt securities are subject to a periodic impairment review. For investments in an unrealized loss position, the Company determines whether a credit loss exists by considering information about the collectability of the instrument, current market conditions and reasonable and supportable forecasts of economic conditions. The Company recognizes an allowance for credit losses, up to the amount of the unrealized loss when appropriate, and writes down the amortized cost basis of the investment if it is more likely than not that the Company will be required or will intend to sell the investment before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in “Other expense, net,” and unrealized losses not related to credit losses are recognized in “Accumulated other comprehensive loss.” There are no allowances for credit losses for the periods presented.InventoryInventory was comprised of the following (in thousands):March 31,2025December 31,2024Purchased materials$36,180 $38,930 Work in progress23,238 27,441 Finished goods15,292 16,736 Inventory$74,710 $83,107 Property and Equipment, NetProperty and equipment, net consisted of the following (in thousands):March 31,2025December 31,2024Land$36,765 $36,765 Building147,235 147,094 Laboratory equipment and machinery 73,792 72,498 Computer equipment and software15,008 14,953 Furniture and fixtures9,745 9,586 Leasehold improvements90,180 89,567 Construction in progress4,475 5,152 Total property and equipment377,200 375,615 Less: accumulated depreciation and amortization (131,113)(122,967)Property and equipment, net$246,087 $252,648 During the three months ended March 31, 2025, the Company recorded impairment charges of $0.1